Vaccination is one of the preeminent systems of promoting global health. Measles, mumps, rubella and HPV are all currently preventable by vaccines developed in the last century. Scientists are currently seeking to develop a universal flu vaccine. As more vaccines come into production, the method for developing these life saving drugs has evolved from relying on cultured mammalian cells to instead utilizing recombination technology, such as that described in the present invention. By developing an automated gene synthesis process, the scientists behind this patent are streamlining and improving the quality of the vaccine development process, to the benefit of the world at large.
None that I can see. Creating a more reliable system for oligonucleotide synthesis has merit for a variety of health and biological applications, and provides exciting possibilities for improving global vaccination availability.